Roflumilast has the potential to be used in a large segment of the COPD population. COPD is one of the leading causes of morbidity and mortality, occurring in approximately 10% of the population in ...
A new study in The American Journal of Pathology details a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback